These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 542192)

  • 1. Estrogen receptor determination in percutaneous bone marrow biopsies of patients with metastatic breast cancer.
    Wortman JE; Rundles RW; Moore JO; McCarty KS; McCarty KS
    Med Pediatr Oncol; 1979; 7(3):277-83. PubMed ID: 542192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estrogen receptor profile of patients with breast cancer metastatic to bone marrow.
    Budd GT
    J Surg Oncol; 1983 Nov; 24(3):167-9. PubMed ID: 6632904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prediction of hormonal dependency of mammary cancer.
    Block GE; Jensen EV; Polley TZ
    Ann Surg; 1975 Sep; 182(3):342-52. PubMed ID: 169754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of estrogen receptor in bone marrow from patients with metastatic breast cancer.
    Berger U; Mansi JL; Wilson P; Coombes RC
    J Clin Oncol; 1987 Nov; 5(11):1779-82. PubMed ID: 3681367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acquisition of metastatic tissue from patients with bone metastases from breast cancer.
    Hilton JF; Amir E; Hopkins S; Nabavi M; DiPrimio G; Sheikh A; Done SJ; Gianfelice D; Kanji F; Dent S; Barth D; Bouganim N; Al-Najjar A; Clemons M
    Breast Cancer Res Treat; 2011 Oct; 129(3):761-5. PubMed ID: 21113656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Iliac crest needle biopsy as a method for determining estrogen receptors in bone metastases from breast cancer.
    Manegold C; Klinga K; Krempien B; Schettler G
    Oncology; 1989; 46(1):31-4. PubMed ID: 2915891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discordance between receptor status in primary and metastatic breast cancer: an exploratory study of bone and bone marrow biopsies.
    Amir E; Ooi WS; Simmons C; Kahn H; Christakis M; Popovic S; Kalina M; Chesney A; Singh G; Clemons M
    Clin Oncol (R Coll Radiol); 2008 Dec; 20(10):763-8. PubMed ID: 18824337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estrogen receptor status in breast cancer.
    Wright CJ
    Can J Surg; 1980 Jul; 23(4):316-7. PubMed ID: 7417890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oestrogen and progesterone receptor status in bone biopsy specimens from patients with breast cancer.
    Frenay M; Milano G; Formento JL; Francoual M; Moll JL; Namer M
    Eur J Cancer; 1991; 27(2):115-8. PubMed ID: 1827270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of operative devascularization on estrogen and progesterone receptor levels in breast cancer specimens.
    Teicher I; Tinker MA; Auguste LJ; Laufer H; Stein TA; Wise L
    Surgery; 1985 Oct; 98(4):784-91. PubMed ID: 4049250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogen receptors and breast cancer: prognostic and therapeutic implications.
    Gapinski PV; Donegan WL
    Surgery; 1980 Sep; 88(3):386-93. PubMed ID: 7414516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple estrogen receptor assays in human breast cancer.
    Hull DF; Clark GM; Osborne CK; Chamness GC; Knight WA; McGuire WL
    Cancer Res; 1983 Jan; 43(1):413-6. PubMed ID: 6847780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endocrine ablation for metastatic breast cancer: a reappraisal of hormone receptors.
    Moseley HS; Peetz ME; Keenan EJ; Awrich AE; Fletcher WS
    Am J Surg; 1980 Jul; 140(1):164-72. PubMed ID: 7396080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of monoclonal antibody for assessment of estrogen receptor content in fine-needle aspiration biopsy specimen from patients with breast cancer.
    Masood S
    Arch Pathol Lab Med; 1989 Jan; 113(1):26-30. PubMed ID: 2462858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical applications of receptor measurements in breast cancer.
    Holdaway IM; Mountjoy KG; Harvey VJ; Allen EP; Stephens EJ
    Br J Cancer; 1980 Jan; 41(1):136-9. PubMed ID: 7362774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Steroid-hormone receptors in breast cancer.
    Wittliff JL
    Cancer; 1984 Feb; 53(3 Suppl):630-43. PubMed ID: 6692266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discordant hormone receptor and human epidermal growth factor receptor 2 status in bone metastases compared to primary breast cancer.
    Aurilio G; Monfardini L; Rizzo S; Sciandivasci A; Preda L; Bagnardi V; Disalvatore D; Pruneri G; Munzone E; Della Vigna P; Renne G; Bellomi M; Curigliano G; Goldhirsch A; Nolè F
    Acta Oncol; 2013 Nov; 52(8):1649-56. PubMed ID: 23327413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of hormone receptor status between circulating tumor cells, primary tumor, and metastasis in breast cancer patients.
    Kalinsky K; Mayer JA; Xu X; Pham T; Wong KL; Villarin E; Pircher TJ; Brown M; Maurer MA; Bischoff FZ
    Clin Transl Oncol; 2015 Jul; 17(7):539-46. PubMed ID: 25613123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics and distribution of receptors for [D-TRP6]-luteinizing hormone-releasing hormone, somatostatin, epidermal growth factor, and sex steroids in 500 biopsy samples of human breast cancer.
    Fekete M; Wittliff JL; Schally AV
    J Clin Lab Anal; 1989; 3(3):137-47. PubMed ID: 2569034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estrogen receptor in breast cancer of the Japanese.
    Nomura Y
    Gan; 1976 Oct; 67(5):703-11. PubMed ID: 190078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.